Search for: "AMGEN INC. v. PRICE et al"
Results 1 - 20
of 25
Sorted by Relevance
|
Sort by Date
Judge Sleet Grants Amgen’s Motion to Dismiss Genetech’s Commercial Marketing Claim Without Prejudice
20 Apr 2018, 8:51 am
Sleet in Genentech, Inc. et al. v. [read post]
12 Apr 2017, 5:00 am
Doe et al., No. 16-222-cv, 2016 BL 292694 (2d Cir. [read post]
12 Apr 2021, 5:55 am
On March 29, the United States Supreme Court heard oral argument in Goldman Sachs Group, Inc., et al. v. [read post]
12 Oct 2011, 11:56 am
Amgen, Inc. et al., No. 1:06-cv-10972-WGY, (D. [read post]
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
18 Nov 2011, 6:58 am
Amgen et al., it was also the basis for a securities lawsuit alleging that a retirement investor was misled by public statements made by Amgen Inc. and four of its officers about the anemia drugs Aranesp and Epogen. [read post]
10 Sep 2020, 3:00 am
In Immunex Corp. et al. v. [read post]
31 Dec 2023, 4:29 pm
Goldsmith et al. [read post]
12 Mar 2013, 8:03 am
Amgen Inc., et al. v. [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
9 Oct 2013, 4:30 am
Amgen Inc., et al., 2013 U.S. [read post]
13 May 2009, 8:00 pm
Amgen Inc. v. [read post]
2 Jan 2019, 10:26 am
Delta Airlines Inc., et al., the 11th Circuit noted that, “while Fifth Third may have changed the legal analysis of our prior decision, it does not alter the outcome. [read post]
4 Aug 2022, 7:54 pm
Pfizer, Inc. v. [read post]
12 Jan 2017, 7:01 am
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
